Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.

The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
General8 hours ago
Mollie O’Callaghan crushes 200m short course world record as post-Titmus era begins
-
Noosa News11 hours ago
Five suspected rat poison cases detected in South East Queensland
-
Noosa News11 hours ago
Horror weekend of motorbike crashes as four riders killed on Aussie roads within hours
-
General17 hours ago
Death doulas, family-led funerals and the deathcare movement hope to change the way we die